Your browser doesn't support javascript.
loading
Clinical efficacy of retreatment of daratumumab-based therapy (D2) in daratumumab-refractory multiple myeloma.
Abdallah, Al-Ola; Mahmoudjafari, Zahra; Ahmed, Nausheen; Cui, Wei; Shune, Leyla; McGuirk, Joseph; Mohan, Meera; Mohyuddin, Ghulam Rehman; Afrough, Aimaz; Alkharabsheh, Omar; Atrash, Shebli.
Afiliación
  • Abdallah AO; Division of Hematologic Malignancies & Cellular Therapeutics, University of Kansas Medical Center, Westwood, Kansas, USA.
  • Mahmoudjafari Z; US Myeloma Innovations Research Collaborative (USMIRC), Westwood, Kansas, USA.
  • Ahmed N; US Myeloma Innovations Research Collaborative (USMIRC), Westwood, Kansas, USA.
  • Cui W; University of Kansas Medical Center, Westwood, Kansas, USA.
  • Shune L; Division of Hematologic Malignancies & Cellular Therapeutics, University of Kansas Medical Center, Westwood, Kansas, USA.
  • McGuirk J; US Myeloma Innovations Research Collaborative (USMIRC), Westwood, Kansas, USA.
  • Mohan M; US Myeloma Innovations Research Collaborative (USMIRC), Westwood, Kansas, USA.
  • Mohyuddin GR; University of Kansas Medical Center, Westwood, Kansas, USA.
  • Afrough A; Division of Hematologic Malignancies & Cellular Therapeutics, University of Kansas Medical Center, Westwood, Kansas, USA.
  • Alkharabsheh O; US Myeloma Innovations Research Collaborative (USMIRC), Westwood, Kansas, USA.
  • Atrash S; Division of Hematologic Malignancies & Cellular Therapeutics, University of Kansas Medical Center, Westwood, Kansas, USA.
Eur J Haematol ; 110(6): 626-632, 2023 Jun.
Article en En | MEDLINE | ID: mdl-36752328
Asunto(s)
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Mieloma Múltiple Tipo de estudio: Diagnostic_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Aged / Humans Idioma: En Año: 2023 Tipo del documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Mieloma Múltiple Tipo de estudio: Diagnostic_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Aged / Humans Idioma: En Año: 2023 Tipo del documento: Article